Table 3.
Summary of Health-Related Quality of Life (HRQoL) Scores (PROMIS Preference, PROPr) of DISTINCT CMM and SCS Treatments at Six months
DISTINCT SCS | DISTINCT CMM | |||
---|---|---|---|---|
Baseline | 6 Months | Baseline | 6 Months | |
Count | 79 | 79 | 55 | 55 |
Mean (SD) | 0.154 (0.094) | 0.343 (0.155) a | 0.152 (0.093) | 0.162 (0.123) a |
Median | 0.139 | 0.302 | 0.143 | 0.142 |
[Min, Max] | [−0.005, 0.399] | [0.057, 0.742] | [−0.005, 0.441] | [−0.013, 0.609] |
Notes: Authors’ calculations from the patient-level data collected using PROMIS-29+2 Profile v2.1 (PROPr) during DISTINCT trial. This table summarizes the Health-Related Quality of Life (HRQoL) metric derived from PROPr. The HRQoL metric ranges from 0 (as bad as dead) to 1 (perfect or ideal health). The mean HRQoL scores show a significant difference in the quality-of-life between patients in DISTINCT SCS vs DISTINCT CMM therapies at six months though the difference is marginal in the baseline between the two groups. a p < 0.001.
Abbreviations: CMM, Conventional Medical Management; PROMIS, Patient-Reported Outcome Measure Information System; SCS, Spinal Cord Stimulation; SD, Standard Deviation.